EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level  |
|---|
   2.3.1.255 | Intellectual Disability |
33103328 |
Variants in NAA15 cause pediatric hypertrophic cardiomyopathy. |
causal interaction
diagnostic usage
unassigned |
3
1
0 |
| 2.3.1.255 | Neoplasms |
19716809 |
Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation. |
ongoing research
unassigned |
4
0 |
| 2.3.1.255 | Neoplasms |
23557624 |
Design, Synthesis, and Kinetic Characterization of Protein N-Terminal Acetyltransferase Inhibitors. |
causal interaction
diagnostic usage
unassigned |
4
1
0 |
| 2.3.1.255 | Prostatic Neoplasms |
27659526 |
Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. |
causal interaction
ongoing research
unassigned |
3
2
0 |
| 2.3.1.255 | Thyroid Neoplasms |
20178098 |
Depletion of the human N(alpha)-terminal acetyltransferase A (hNatA) induces p53-dependent apoptosis and p53-independent growth inhibition. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 2.3.1.255 | Thyroid Neoplasms |
21351257 |
Depletion of the human N?-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.3.1.255 | Tuberculosis |
27353550 |
Biochemical evidence for relaxed substrate specificity of N?-acetyltransferase (Rv3420c/rimI) of Mycobacterium tuberculosis. |
unassigned |
0 |
| 2.3.1.255 | Heart Defects, Congenital |
33557580 |
Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.3.1.255 | Carcinogenesis |
20592467 |
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
1
2
1 |
| 2.3.1.255 | Carcinoma, Hepatocellular |
20419844 |
LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
4
2
0 |
